With the rise in Covid-19 cases, the Malaysian government has declared that the entire country will be on a movement control order starting 18 March, 2020 and expected to end on 31 March, 2020. Ambu owns and operates a manufacturing plant in Malaysia where a.o. Ambu’s single-use endoscopes are being manufactured. It is currently uncertain whether this order will also apply to the factory or the factory can be exempt as our aScope is one of the few guaranteed sterile bronchoscopes available if you need to do a bronchoscopy despite the Covid-19 situation.
Even in a situation where the Ambu factory in Malaysia will be subject to the movement control order, we expect to have sufficient inventories of aScope and most other products manufactured at the site to avoid any significant disruption to the supply chain within the duration of the movement order.
Assuming that the movement control order expires as stated on 31 March, 2020, we expect that the impact from the Malaysian government action will not have material impact on our guidance as provided at Q1 on 4 February, 2020.
Contact
Investor relations
Michael Højgaard, CFO, tel. +45 4030 4349, email: miho@ambu.com
Nicolai Thomsen, Investor Relations Manager, tel. +45 2620 8047, email: nith@ambu.com
Media
Mikkel Trier Wagner, Director Corporate Communications, tel. +45 4191 0830, email: mtw@ambu.com
Attachment
